Is taro root good for blood sugar?

The starch in taro is structurally distinct from that of potato or white rice. Taro starch granules are among the smallest of any food crop — measuring just 1–4 micrometers compared to 15–100 micrometers in potato starch. This microscopic size makes the granules harder for digestive enzymes to break down efficiently, resulting in slower and more incomplete digestion in the small intestine.

The practical effect is twofold. First, taro has a lower estimated glycemic index than white potato or white rice when cooked under typical conditions. An in vitro study of taro corm estimated its glycemic index at 63.1 ± 2.5, which the authors described as a medium-GI food¹. Second, a meaningful fraction of taro starch escapes digestion entirely, entering the colon as resistant starch. There it is fermented by gut bacteria, producing short-chain fatty acids (particularly butyrate) that fuel colonocytes, support gut barrier integrity, and may reduce colorectal cancer risk.

Cooking taro and then cooling it before eating — and particularly reheating after refrigeration — further increases resistant starch content through retrogradation, the same process that occurs with cooked-and-cooled potato and rice.

Important note on preparation: Raw taro contains calcium oxalate crystals that cause intense throat irritation and skin itching. Taro must be cooked thoroughly — boiled, steamed, or roasted — before eating. This is not a toxicity concern when properly prepared, as cooking eliminates the irritation-causing crystals.

Polyphenols and Antioxidant Activity

Taro corm contains phenolic compounds and flavonoids (205 and 61 mg CAE per 100 g, respectively, in one analysis) and shows measurable antioxidant capacity in free-radical scavenging assays¹. A detailed analysis of taro leaves identified 41 phenolic metabolites — 11 hydroxycinnamic acid derivatives and 30 glycosylated flavonoids — in two varieties³.

A review of taro leaves highlights their high content of bioactive compounds and their antioxidative potential². The leaves are low in calories and rich in proteins, dietary fiber, and micronutrients, but they contain antinutrients such as tannins, phytates, and oxalates, which cooking and varied processing techniques can overcome².

Potassium, Vitamins, and Mineral Profile

A 100g serving of cooked taro provides:

• Potassium: 590–620 mg — among the higher potassium densities of starchy vegetables, supporting blood pressure regulation through the sodium-potassium balance.
• Vitamin C: 4–5 mg, modest but present.
• Vitamin B6: Around 0.33 mg, supporting neurotransmitter synthesis and homocysteine metabolism.
• Vitamin E: Tocopherols that contribute to fat-soluble antioxidant protection.
• Manganese: Supports enzymatic antioxidant defense (as part of manganese superoxide dismutase).
• Magnesium: Around 30–40 mg per serving, contributing to the baseline intake of this commonly deficient mineral.
• Phosphorus: Important for bone mineralization and energy metabolism.

The combination of potassium, magnesium, and fiber makes taro a reasonable addition to dietary approaches for blood pressure management, particularly as a carbohydrate substitute for lower-potassium starchy foods.

Blood Sugar and Metabolic Effects

In an in vitro digestion study, taro corm starch was highly digestible (more than 50% rapidly digestible starch) and the estimated glycemic index was 63.1 ± 2.5, which the authors described as a medium-GI food and a good dietary carbohydrate alternative, especially for diabetic people¹. No human trial of taro's effect on blood glucose is described here, so this is laboratory evidence only.

Taro corms also contain A-1/B-2 α-amylase inhibitors, and anti-hyperglycemic activity is among the activities attributed to taro's bioactive compounds, most of which have been tested in vitro and in vivo⁴.

Anti-Inflammatory and Immune Properties

Taro root extract has demonstrated anti-inflammatory effects in cell and animal models. A methanolic root extract lowered serum nitric oxide, prostaglandin E2, and cytokine levels in a rat paw-edema model, and reduced nitric oxide, prostaglandin E2, and COX-2 and iNOS mRNA expression in LPS-stimulated macrophage cells⁵. Docking analyses showed promising interactions between sinapic acid, one of the phytoconstituents identified in the extract, and COX-2 and iNOS, but the bioactive compound still needs to be isolated and purified.

Taro also contains polysaccharides (taro-4-I polysaccharide and taro polysaccharides 1 and 2, TPS-1 and TPS-2) among the compounds to which its immunomodulatory activity is attributed, and a review of taro corms describes them as boosting the immunological response⁴. This places taro alongside other polysaccharide-rich foods — such as beta-glucan-rich mushrooms and oats — as a food with structural components that the immune system appears to recognize and respond to.

Practical Use

• Boiling and steaming are the most common cooking methods and adequately eliminate oxalates. Cook until fully tender throughout.
• Taro chips: Sliced thin and baked with olive oil — a nutritionally superior substitute for potato chips with better fiber and polyphenol content.
• Poi (Hawaiian fermented taro paste): The traditional Hawaiian form adds probiotic benefits from the fermentation process.
• Taro in soups and curries: The starch thickens broths naturally and absorbs spices well.
• Purple taro varieties (often labeled "ube" in Southeast Asian and Filipino cooking) contain additional anthocyanins from the purple pigment and are visually distinct from standard grey-fleshed taro.

Taro pairs well with coconut milk, which also improves absorption of fat-soluble nutrients. For blood sugar stability, eating taro with protein and fat slows gastric emptying further and reduces the glycemic impact.

See our Resistant Starch page for more on how cooled starches feed gut bacteria, and our Sweet Potato page for comparison with another high-potassium starchy vegetable.

Glycemic Index and Starch Digestibility (Simsek and Nehir El, 2014)

This study published in Food Chemistry measured the in vitro starch digestibility, estimated glycemic index, and antioxidant potential of taro (Colocasia esculenta L. Schott) corm¹. About 60% of the corm's dry matter was starch and its free glucose content was less than 1%. The starch was highly digestible: more than 50% of it was made up of rapidly digestible starch (RDS) fractions. The estimated glycemic index (eGI) of taro corm was 63.1 ± 2.5, which the authors described as a medium-GI food and a good dietary carbohydrate alternative, especially for diabetic people.

The corm's total phenolic and flavonoid content were 205 ± 53 and 61 ± 9 mg CAE/100 g, and its antioxidant capacity, measured by scavenging activity against ABTS and DPPH radicals, was 452 ± 72 and 244 ± 73 mM TEAC/100 g, respectively. Limitations: in vitro starch digestion models are useful approximations but do not fully replicate the complexity of human small intestinal digestion, gut transit time variation, and the influence of the overall meal matrix. Human clinical glucose response studies specifically comparing taro to reference foods are limited in the peer-reviewed literature.

Phytochemical Composition Review (Mitharwal et al., 2022)

This review covered the nutritional, antinutritional, and phytochemical profile of taro leaves, together with the advanced analytical techniques used to identify and quantify them². Taro leaves are low in calories and rich in proteins, dietary fiber, and micronutrients, but their use as food remains limited by a lack of awareness of their nutritional profile and by antinutrients such as tannins, phytates, and oxalates, which the review reports can be overcome by cooking and varied processing techniques. The high content of bioactive compounds and the antioxidative potential of the leaves are said to render several health benefits, such as anticancer, antidiabetic, and anti-inflammatory activity.

The review also discusses the food applications of taro leaves. Limitations: this is a review of the available literature on the leaves rather than a human trial, so the health benefits it describes are potential rather than demonstrated.

Phenolic Profile (Ferreres et al., 2012)

This analytical chemistry study published in the Journal of Agricultural and Food Chemistry identified forty-one phenolic metabolites (11 hydroxycinnamic acid derivatives and 30 glycosylated flavonoids) by HPLC-DAD-ESI/MSn in the leaves of two Colocasia esculenta varieties cultivated in the Azores Islands, 34 of which were reported for the first time in this species³. Phenolics were quantified with a validated HPLC-DAD method. The qualitative profile of the two varieties ("Giant white" and "red") was quite similar, but they differed quantitatively, and luteolin-6-C-hexoside was the compound present in higher amounts in both.

The authors concluded that the established phenolic profile is an added value for the authenticity and quality control of C. esculenta and may be useful in discriminating its varieties. Limitations: this was a compositional analysis of the leaves of two varieties, so it does not by itself show any health effect.

Immunomodulatory and Anticancer Properties (Ribeiro Pereira et al., 2020)

This review in the International Journal of Molecular Sciences covered the anticancer and immunomodulatory benefits of taro corms⁴. It reports that taro corms contain bioactive molecules effective against cancer and cancer-related risk factors (such as carcinogens and biological agents) and against pathophysiological conditions including oxidative stress and inflammation, while controlling metabolic dysfunctions and boosting the immunological response. These effects are achieved by compounds displaying antitumoral, antimutagenic, immunomodulatory, anti-inflammatory, antioxidant, anti-hyperglycemic, and anti-hyperlipidemic activities.

The review attributes taro's bioactivities to a combination of tarin, taro-4-I polysaccharide, taro polysaccharides 1 and 2 (TPS-1 and TPS-2), A-1/B-2 α-amylase inhibitors, monogalactosyldiacylglycerols (MGDGs), digalactosyldiacylglycerols (DGDGs), polyphenols, and nonphenolic antioxidants, and notes that most of these compounds have been purified and successfully challenged in vitro and in vivo. Limitations: effects demonstrated in vitro and in vivo have not been confirmed in human clinical trials. The biological significance of taro-derived compounds in the context of normal dietary intake remains to be established in human studies.

Anti-Inflammatory Activity (Baro et al., 2022)

This study published in the Journal of Ethnopharmacology tested a methanolic root extract of taro (Colocasia esculenta) in a carrageenan-induced rat paw edema model and in LPS-stimulated RAW264.7 macrophage cells⁵. In the in vivo arm, adult male Wistar rats were pre-treated orally with the extract (100, 200, and 400 mg/kg body weight) one hour before the carrageenan injection, with indomethacin (10 mg/kg) as the standard drug. Pre-treatment with 400 mg/kg significantly inhibited the paw inflammation, an inhibition comparable to that of indomethacin, and serum nitric oxide, prostaglandin E2, cytokine, AST, ALT, and ALP levels were considerably lower than in the carrageenan-induced group. In the in vitro arm, the extract (34 μg/ml) inhibited the LPS-stimulated mRNA expression of COX-2 and iNOS and significantly reduced nitric oxide and prostaglandin E2 expression.

Docking analyses showed promising interactions between sinapic acid, one of the phytoconstituents identified in the extract by LC-MS, and both COX-2 and iNOS; the authors concluded that the bioactive compound from taro still needs to be isolated and purified. Limitations: rodent anti-inflammatory models use acute injury paradigms that do not fully replicate chronic low-grade inflammation relevant to human metabolic disease; the doses used (expressed per kg body weight) are difficult to translate directly to human dietary amounts, and the study tested an extract rather than taro eaten as food.

Evidence Strength Summary

The case for taro as a health-supportive starchy vegetable rests on several complementary lines of evidence. An in vitro digestion study estimated the glycemic index of taro corm at 63.1 ± 2.5 (a medium-GI food with a highly digestible starch), and the phenolic content and antioxidant capacity of the corm and the phenolic profile of the leaves have been measured analytically. Direct human clinical trials on taro's metabolic effects are sparse, which is the main gap in the evidence base. Anti-inflammatory and immunomodulatory effects are supported by in vitro and animal studies that are mechanistically coherent, but human translation remains to be established. Overall, taro earns its place as a high-quality starchy vegetable with a nutrient profile that offers advantages over more commonly consumed refined starches.